0001581720-14-000002.txt : 20140512 0001581720-14-000002.hdr.sgml : 20140512 20140509191214 ACCESSION NUMBER: 0001581720-14-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140512 DATE AS OF CHANGE: 20140509 EFFECTIVENESS DATE: 20140512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Loxo Oncology, Inc. CENTRAL INDEX KEY: 0001581720 IRS NUMBER: 462996673 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-217142 FILM NUMBER: 14830793 BUSINESS ADDRESS: STREET 1: 1 LANDMARK SQUARE, SUITE 1122 CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 203-658-4749 MAIL ADDRESS: STREET 1: 1 LANDMARK SQUARE, SUITE 1122 CITY: STAMFORD STATE: CT ZIP: 06901 D 1 primary_doc.xml X0707 D LIVE 0001581720 Loxo Oncology, Inc. 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT CONNECTICUT 06901 203-658-4749 DELAWARE None None Corporation true 2013 Joshua H. Bilenker 1 Landmark Square, Suite 1122 Stamford CT CONNECTICUT 06901 Executive Officer Director Dov Goldstein 1 Landmark Square, Suite 1122 Stamford CT CONNECTICUT 06901 Director Avi Naider 1 Landmark Square, Suite 1122 Stamford CT CONNECTICUT 06901 Director David Bonita 1 Landmark Square, Suite 1122 Stamford CT CONNECTICUT 06901 Director Keith Flaherty 1 Landmark Square, Suite 1122 Stamford CT CONNECTICUT 06901 Director James Barrett 1 Landmark Square, Suite 1122 Stamford CT CONNECTICUT 06901 Director Steven Elms 1 Landmark Square, Suite 1122 Stamford CT CONNECTICUT 06901 Director Biotechnology Decline to Disclose 06b false 2014-04-24 false true true Series B Preferred Stock false 0 23888747 23888747 0 false 7 0 0 0 false Loxo Oncology, Inc. Joshua H. Bilenker Joshua H. Bilenker President and CEO 2014-05-09